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Research
Cadmium is a widespread environ  mental 
  pollutant associated with adverse health 
effects, including cancer, kidney damage, low 
bone-mineral density, bone fractures, and 
probably impaired early-life development 
(Engström A et al. 2011; Järup and Åkesson 
2009; Kippler et al. 2011). The general popu-
lation is exposed to cadmium mainly through 
the diet, in particular, through cereals and 
vegetables, and through smoking. Potential 
mechanisms of cadmium toxicity described 
so far include interactions with sulfhydryl 
groups and endocrine disruption, as well as 
oxidative stress (Hartwig 2010; Johnson et al. 
2003; Monroe and Halvorsen 2006; Xu et al. 
2011; Yu et al. 2010).
DNA methyla  tion is essential for embryo-
genesis and for maintaining cell-lineage–
specific gene expression throughout life. 
Dysregulation of epigenetic processes, such as 
DNA methyla  tion, may lead to impaired child-
hood development or chronic diseases later 
in life, including cancer (Faulk and Dolinoy 
2011; Feinberg 2007; Robins et al. 2011). In 
carcinogenesis, global DNA methyla  tion is 
generally decreased, whereas specific regions 
of DNA that contain tumor suppressor genes 
often show hypermethyla  tion (Chalitchagorn 
et al. 2004; Deng et al. 2006; Gaudet et al. 
2003; Robertson and Jones 2000). In vitro 
studies have indicated that cadmium may 
interfere with epigenetic processes: Both gene-
specific DNA hyper  methyla  tion with gene 
silencing of p16INK4a [CDKN2A (cyclin-
dependent kinase inhibitor 2A)], RASSF1 [Ras 
association (RalGDS/AF-6) domain family 
member 1], and MT1 (metallo  thionein 1) 
genes, and global DNA hypomethyla  tion 
have been reported (Benbrahim-Tallaa et al. 
2007; Huang et al. 2008; Jiang et al. 2008; 
Martinez-Zamudio and Ha 2011; Takiguchi 
et al. 2003). However, there are no reports on 
the epigenetic effects of cadmium exposure 
in humans.
The aim of this study was to evaluate 
whether environmental cadmium exposure, 
mainly through the normal diet, may affect 
DNA methyla  tion, both of repetitive genetic 
elements (as a proxy for global methyla  tion) 
and of specific genes.
Materials and Methods
Participants. We studied 202 women living 
in the Andean plateau (3,800 m above sea 
level) in northern Argentina, an area that has 
minimal industrial or vehicle-derived pollu-
tion. Most of the study participants (161) 
were from the village of San Antonio de los 
Cobres, which has about 5,000 inhabitants. 
The 41 remaining participants were from 
small surrounding villages. The study area 
is known to have elevated concentrations of 
arsenic (Vahter et al. 1995), but not cadmium 
(Concha et al. 2010), in the drinking water.
The study individuals were recruited with 
the assistance of local medical personnel, except 
in the small mining village of Tolar Grande, 
where we went from house to house to explain 
the study and invited the adults to participate. 
We included only women because men were 
often away from home for longer periods for 
work and were therefore likely to be exposed 
to a different variety of environmental hazards. 
Furthermore, women may be more susceptible 
to cadmium exposure than are men because 
of their increased gastro  intestinal cadmium 
absorption when iron stores are low (Berglund 
et al. 1994), as is common in women of child-
bearing age. Only four study participants 
smoked cigarettes, and one reported drinking 
alcohol, but almost half (46.5%) reported that 
they chewed coca leaves. As reported before, 
interviews with the study participants revealed 
that almost all women drank exclusively public 
water and that their diets consisted mainly of 
corn, beans, chicken, and pork (Broberg et al. 
2011). Only three women reported taking 
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Ba c k g r o u n d: Cadmium, a common food pollutant, alters DNA methyla  tion in vitro. Epigenetic 
effects might therefore partly explain cadmium’s toxicity, including its carcinogenicity; however, 
human data on epigenetic effects are lacking.
oB j e c t i v e: We evaluated the effects of dietary cadmium exposure on DNA methyla  tion, consider­
ing other environmental exposures, genetic predisposition, and gene expression.
Me t h o d s : Concentrations of cadmium, arsenic, selenium, and zinc in blood and urine of non­
smoking women (n = 202) from the northern Argentinean Andes were measured by inductively 
coupled mass spectrometry. Methyla  tion in CpG islands of LINE-1 (long interspersed nuclear 
element­1; a proxy for global DNA methyla  tion) and promoter regions of p16 [cyclin­dependent 
kinase inhibitor 2A (CDKN2A)] and MLH1 (mutL homolog 1) in peripheral blood were measured 
by bisulfite polymerase chain reaction pyrosequencing. Genotyping (n = 172) for the DNA (cytosine­
5­)­methyltransferase 1 gene (DNMT1 rs10854076 and rs2228611) and DNA (cytosine­5­)­methyl­
transferase 3 beta gene (DNMT3B rs2424913 and rs2424932) was performed with Sequenom 
iPLEX GOLD SNP genotyping; and gene expression (n = 90), with DirectHyb HumanHT­12 
(version 3.0).
re s u l t s: Cadmium exposure was low: median concentrations in blood and urine were 0.36 and 
0.23 µg/L, respectively. Urinary cadmium (natural log transformed) was inversely associated with 
LINE-1 methyla  tion (β = –0.50, p = 0.0070; β = –0.44, p = 0.026, adjusted for age and coca chew­
ing) but not with p16 or MLH1 methyla  tion. Both DNMT1 rs10854076 and DNMT1 rs2228611 
polymorphisms modified associations between urinary cadmium and LINE-1 (p­values for interaction 
in adjusted models were 0.045 and 0.064, respectively). The rare genotypes demonstrated stronger 
hypomethyla  tion with increasing urinary cadmium concentrations. Cadmium was inversely associated 
with DNMT3B (rS = –0.28, p = 0.0086) but not with DNMT1 expression (rS = –0.075, p = 0.48).
co n c l u s i o n: Environmental cadmium exposure was associated with DNA hypomethyla  tion in 
peripheral blood, and DNMT1 genotypes modified this association. The role of epigenetic modifica­
tions in cadmium­associated diseases needs clarification.
key wo r d s: cadmium, DNMT1, DNMT3B, epigenetic, genotype, LINE-1, MLH1, p16, pyro­
sequencing. Environ Health Perspect 120:879–884 (2012).  http://dx.doi.org/10.1289/ehp.1104600 
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any medication at the time of the study: one 
being treated for gastritis and two for hyper-
tension. No women reported any history of or 
current malignancy.
We measured two biomarkers of cadmium 
exposure: blood cadmium, reflecting ongoing 
exposure, and urinary cadmium, reflecting 
long-term exposure (Järup and Åkesson 2009). 
Both oral and written informed consent was 
provided by all the study participants. The 
study was approved by the Ministry of Health 
in Salta, Argentina, and the Regional Ethical 
committee at Karolinska Institute, Sweden.
Blood and urine collection. All biologi-
cal samples were nonfasting spot samples 
collected during the daytime at local health 
clinics or the hospital in San Antonio de los 
Cobres. Peripheral blood for DNA extraction 
(n = 202) was collected in K2EDTA tubes 
(Vacuette®; Vacuette Bio One, Frickenhausen, 
Greiner, Germany), blood for element analysis 
(n = 202) in lithium heparin tubes (Vacuette 
Bio One), and blood for RNA extraction 
(n = 122) in PAXgene Blood RNA Tubes 
(Becton Dickinson, Franklin Lakes, NJ, USA). 
Spot urine samples were collected and pro-
cessed as described previously (Concha et al. 
1998). Blood, plasma, and urine samples were 
kept at –20°C before and after the transport 
(with cooling blocks) to Sweden for analysis.
Analysis of elements in blood and urine. 
We measured cadmium in blood and urine, 
and selenium and zinc in blood, because these 
elements may influence DNA methyla  tion or 
one-carbon metabolism (Hong et al. 2000; 
Pilsner et al. 2011; Smeester et al. 2011). 
Cadmium, selenium, and zinc were measured 
using inductively coupled plasma mass spec-
trometry (ICP-MS; model 7500ce; Agilent 
Technologies, Waldbronn, Germany) with a 
collision/  reaction cell system to remove poten-
tial interferences, particularly interference 
from molybdenum in the cadmium analysis 
(Concha et al. 2010; Kippler et al. 2009). The 
limit of detection (LOD; 3 × SD of blank 
values) was 0.001 µg/L for urinary cadmium, 
and no sample had a cadmium concentration 
below the LOD. For blood measurements, 
the LOD was 0.011, 0.081, and 0.49 µg/L 
for cadmium, selenium, and zinc, respectively, 
and no samples were below the LOD for any 
of the compounds measured. Analytical accu-
racy was controlled by analyzing commer-
cially available reference materials (Concha 
et al. 2010; Kippler et al. 2009). Because the 
study area is known to have varying concen-
trations of arsenic in the drinking water, and 
because arsenic may alter DNA methyla  tion 
(Chanda et al. 2006; Smeester et al. 2011), we 
also assessed exposure to arsenic by measuring 
arsenic metabolites (inorganic arsenic, methyl-
arsonic acid, and dimethylarsinic acid) in urine 
using HPLC/ICP-MS (Engström et al. 2010). 
Additionally, the study area was recently found 
to have elevated concentrations of boron, lith-
ium, and cesium in the drinking water, and we 
measured these elements in urine by ICP-MS 
(Concha et al. 2010). To control for variation 
in urine dilution, we adjusted the cadmium 
and arsenic concentrations in urine to the 
mean specific gravity of urine (1.020 g/mL) 
(Nermell et al. 2008). We measured the speci-
fic gravity of the urine samples with a digital 
refrac  tometer (model RD 712 clinical refrac-
tometer; EUROMEX, Arnhem, Holland).
Polymerase chain reaction (PCR) and 
pyrosequencing. DNA was isolated using the 
QIAamp® DNA Blood Midi kit (Qiagen, 
Hilden, Germany). We used the EpiTect® kit 
(Qiagen) to treat 1 µg of DNA (50 ng/µL) 
with bisulfite. Bisulfite treatment of DNA 
converts unmethylated cytosine residues 
into uracil, leaving the methylated cytosine 
unchanged; these changes can be quantified 
by pyro  sequencing. The bisufite-treated DNA 
was stored at –20°C until used for PCR.
We used the bisulfite-treated DNA 
(0.6–1 µL) in a 15- to 25-µL PCR reaction 
using the Pyromark PCR kit (Qiagen). One 
of the PCR primers was biotinyla  ted, and the 
PCR product was purified using Streptavidin 
Sepharose High Performance beads (Amersham 
Biosciences, Uppsala, Sweden). The Sepharose 
beads with the immobilized PCR products were 
purified, washed, and denatured with 0.2 M 
NaOH and washed again using a vacuum 
prep tool (Pyrosequencing Inc., Westborough, 
MA, USA). After annealing 12 µL of the 
0.3-µmol/L pyrosequencing primer to the 
purified single-stranded PCR product, we per-
formed pyrosequencing using the PSQ HS96 
Pyrosequencing System (Qiagen). The degree 
of methyla  tion was expressed as the percent-
age of methyla  ted cytosines over the sum of 
methylated and unmethylated cytosines. We 
verified bisulfite conversion using non-CpG 
(cytosine–guanine dinucleotide) cytosine resi-
dues as built-in controls, and complete conver-
sion of cytosine at a non-CpG site indicated 
successful bisulfite conversion.
LINE­1, p16, and MLH1 methyla  tion. 
As a surrogate measure of genome-wide 
methyla  tion, we measured peripheral blood 
DNA methyla  tion in the long interspersed 
nuclear element-1 (LINE-1) retrotransposable 
elements that make up about 17% of human 
DNA (Lander et al. 2001). We also measured 
methyla  tion of CpG islands in p16 [cyclin-
dependent kinase inhibitor 2A (CDKN2A)], 
a tumor suppressor gene that is often hyper-
methylated in tumors and may be relevant in 
cadmium-induced tumorigenesis (Benbrahim-
Tallaa et al. 2007), and in the MLH1 (mutL 
homolog 1) gene, a component of the DNA 
mismatch repair pathway.
Commercially available kits (Qiagen) 
were used to measure the methyla  tion of four 
CpG sites in LINE-1 [positions 305–331 of 
GenBank accession no. X58075 (National 
Library of Medicine 2012a)], seven CpG sites 
in p16 (+148 to +174 in exon 1; GenBank 
accession no. L27211), and four CpG sites 
in MLH1 (–209 to –188; GenBank accession 
no. U07418) following the manufacturer’s 
instructions. A single PCR fragment spanning 
a part of each genetic element was amplified, 
and the degree of methyla  tion was analyzed in 
a single pyrosequencing reaction using 20 µL 
PCR product for LINE-1, 3 µL for p16, and 
4 µL for MLH1. The samples were analyzed 
as singlets for LINE-1 and as triplicates for 
p16 and MLH1. We selected 10% of the 
samples at random and reassayed them. The 
repeatability of the method, expressed as the 
variation in coefficients, was 2.0%, 36.7%, 
and 26.4%, for LINE-1, p16, and MLH1 
methyla  tion, respectively. Previous reports 
have validated pyrosequencing as an effective 
technique for measuring LINE-1 methyla  tion 
at the population level (Schernhammer et al. 
2010; Tarantini et al. 2009).
Genotyping  and  gene  expression. 
Genotyping for polymorphisms of DNA 
methyltransferase-1 [(cytosine-5-)-methyl-
transferase 1] (DNMT1 rs10854076 and 
rs2228611, one from each linkage dis  equilib-
rium block in the gene) and DNA (cytosine-
5-)-methyltransferase 3 beta (DNMT3B 
rs2424913 and rs2424932) was performed 
on DNA from peripheral blood with 
iPLEX GOLD SNP genotyping (Sequenom 
Inc., San Diego, CA, USA) the Swegene 
DNA facility at Malmö University Hospital 
(Malmö, Sweden), as described previously 
(Engström K et al. 2011). DNMT1 rs2228611 
[minor allele frequency (MAF) = 40%] is a 
synonymous amino acid exchange, whereas 
rs10854076 (MAF = 35%) is situated in an 
intron. DNMT3B rs2424913 (MAF = 5%) 
and rs2424932 (MAF = 6%) are both situ-
ated in introns. The functional impact of these 
polymorphisms on DNA methyla  tion, if any, 
is unknown.
RNA was extracted using the PAXgene 
Blood RNA kit (PreAnalytiX, Hombrechtikon, 
Switzerland) and stored at –80°C until isola-
tion. We evaluated RNA concentration and 
purity using a NanoDrop spectrophotome-
ter (NANODROP 1000; Thermo Scientific, 
Wilmington, DE, USA), and we evaluated 
the RNA integrity number (RIN) using a 
Bioanalyzer 2100 (Agilent Technologies, Santa 
Clara, CA, USA). The results indicated good 
RNA quality (RIN > 7.5) for all of the sam-
ples. Of 122 available PAX tubes for RNA 
extraction, 90 samples were selected for gene 
expression analysis based on their RNA quality 
and the amount of RNA left for analysis [for 
descriptive characteristics of this subset of the 
study population, see Supplemental Material, 
Table 1 (http://dx.doi.org/10.1289/ehp. 
1104600)]. Of the 90 individuals selected, Cadmium influences DNA methylation
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75 were not first-degree relatives, and they were 
selected for the analysis of genetic effect modi-
fication on the association between cadmium 
exposure and epigenetic markers. DirectHyb 
HumanHT-12 (version 3.0; Illumina, San 
Diego, CA, USA) was used for gene expres-
sion analysis according to the manufacturer’s 
instructions at the SCIBLU (Swegene Centre 
for Integrative Biology at Lund University) 
facility at Lund University. Background sig-
nals were filtered from the gene expression 
data by BioArray Software Environment 
(BASE) (Vallon-Christersson et al. 2009). The 
DirectHyb HumanHT-12 (HT-12) array 
(Illumina) included one DNMT1 transcript 
and five DNMT3B transcripts [the gene has 
alternatively spliced transcripts (National 
Library of Medicine 2012b)]. No LINE-1 tran-
scripts were included on the array.
Statistical analyses. We used the averages 
of the relative amounts of methylated cytosine 
residues in the four, seven, and four CpG 
sites measured in LINE-1, p16, and MLH1, 
respectively to determine the overall methyla-
tion level for each genetic element analyzed 
in a given sample. We used Spearman’s rank 
correlation analysis to estimate univariate cor-
relations between cadmium in blood or urine 
and methyla  tion and gene expression, as well 
as correlations with potential covariates such 
as age, body weight, body mass index (BMI), 
use of coca leaves, and zinc and selenium con-
centrations in whole blood.
We first evaluated the gene methyla-
tion by quintiles of cadmium exposure [see 
Supplemental Material, Figures 1–3 (http://
dx.doi.org/10.1289/ehp.1104600)] and by 
scatter plots. Because visual inspection of the 
plots suggested linear relationships, we used 
linear regression models to estimate associa-
tions (β-coefficients) of cadmium in blood and 
urine with the epigenetic markers. We per-
formed a multivariable-adjusted analysis con-
trolling first for age and coca chewing (yes/no) 
because age and coca chewing were correlated 
with at least one of the epigenetic markers 
(p-values < 0.2) and because cadmium expo-
sure–outcome coefficients changed by > 5% 
when they were included in models. To assess 
the robustness of associations, we addition-
ally controlled for urinary arsenic, boron, lith-
ium, and cesium (modeled as untransformed 
continuous variables). In the linear regression 
analyses, urine and blood cadmium concen-
trations were natural log (ln) transformed to 
obtain normal distributions of the residuals 
and a better linear fit with the outcomes.
The influence of DNMT1 genotypes (effect 
modification) on the association between uri-
nary cadmium concentration and LINE-1 
methyla  tion was analyzed in individuals that 
were not first-degree relatives (n = 172). This 
analysis was performed by modeling a cross-
product term between genotype (for DNMT1 
as an ordinal variable with three categories, 
and for DNMT3B dichotomized because 
few individuals were variant homozygotes) 
and lower-order terms for genotype and ln-
urinary cadmium concentrations. Analyses 
were then stratified by genotype to estimate 
associations between urinary cadmium and 
LINE-1 methyla  tion according to each geno-
type. In addition, we used stratified models 
to estimate associations between urinary cad-
mium and DNMT1 expression according to 
genotype in the 75 participants that were not 
first-degree relatives. Associations between 
genotypes and the expression of DNMTs were 
estimated using analysis of variance with and 
without adjustment for age and coca chew-
ing. We did not adjust p-values for multiple 
comparisons. A p-value < 0.05 was considered 
statistically significant. All statistical analyses 
were performed using SPSS (version 18; SPSS, 
Chicago, IL, USA).
Results
Descriptive data for the study participants and 
element concentrations in blood and urine are 
presented in Table 1. In general, the women 
were relatively short, and, using the conven-
tional cut-offs for overweight (BMI 25–29.9) 
and obesity (BMI > 30), about half of them 
were overweight and 18% obese. Blood con-
centrations of hemoglobin, selenium, and zinc 
indicated adequate nutritional status. Cadmium 
concentrations were 0.013–1.5 µg/L in urine 
(median, 0.23 µg/L) and 0.17–1.1 µg/L 
in blood (median, 0.36 µg/L). Four women 
who reported smoking had cadmium con-
centrations of 0.045–0.24 µg/L in urine and 
0.18–0.52 µg/L in blood. Median LINE-1, p16, 
and MLH1 methyla  tion levels were 86.2%, 
3.4%, and 4.2%, respectively (Table 1).
The epigenetic markers were positively 
correlated with each other: the correlation 
between p16 and MLH1 methyla  tion being 
the strongest (rS = 0.78, p < 0.01), followed by 
LINE-1 and MLH1 (rS = 0.51, p < 0.01), and 
LINE-1 and p16 (rS = 0.42, p < 0.01). Urinary 
cadmium concentrations were negatively cor-
related with LINE-1 methyla  tion (rS = –0.19, 
p < 0.01). Blood cadmium concentrations 
were not correlated with LINE-1 (rS = 0.046) 
but were positively correlated with urinary 
cadmium concentration (rS = 0.46, p < 0.01). 
Neither urinary cadmium nor blood cadmium 
concentrations were correlated with p16 or 
MLH1 methyla  tion (rS < 0.1). None of the 
nutritional markers (BMI, hemoglobin, sele-
nium, and zinc) were significantly correlated 
with the epigenetic markers (rS < 0.11).
In the linear regression analysis, the 
ln-trans  formed urinary cadmium concentra-
tions of all women (n = 202) were inversely 
associated with LINE-1 methyla  tion [for 
unadjusted model: β = –0.50; 95% confi-
dence interval (CI): –0.86, –0.14; p = 0.0070; 
Table 2]. Estimates did not change much 
Table 1. Descriptive information of the women 
and biomarkers analyzed.a
Variable Median
5th–95th 
percentile
Age (years) 34 18–64
Body weight (kg) 57.0 44.0–79.9
Height (cm) 152 144–161
BMI (kg/m2) 24.7 18.8–35.0
Blood hemoglobin (g/L) 155 130–180
Urinary creatinine (g/L)b 0.90 0.52–1.4
Coca chewing (%) 46.5
Methyla  tion (%)
LINE1c 86.2 83.5–89.3
p16d 3.4  1.7–5.8
MLH1e 4.2 1.2–7.1
Blood measures
Cadmium (μg/L) 0.36 0.20–0.76
Selenium (μg/L) 176 150–221
Zinc (mg/L) 6.8 5.5–8.2
Urinary measures
Cadmium (μg/L)b 0.23 0.091–0.70
Arsenic (μg/L)b 230 21–545
Boron (mg/L)b 14.6 2.6–27.9
Cesium (μg/L)b 470 26.1–880
Lithium (mg/L)b 3.9 0.27–10.4
an = 202 subjects, except for creatinine (n = 194) and 
blood selenium (n = 201) analyses. bAdjusted for spe-
cific gravity of urine (1.020 g/mL). cAverage of relative 
amounts of methylated cytosines in four CpGs, positions 
305–331, GenBank accession no. X58075. dAverage of 
relative amounts of methylated cytosines in seven CpGs, 
positions 148–174, accession no. L27211. eAverage of 
relative amounts of methylated cytosines in four CpGs, 
positions –209 to –188, accession no. U07418.
Table 2. Associations between ln-transformed blood and urinary cadmium concentration (μg/L) and percent 
methyla  tion of LINE1, p16, and MLH1.
LINE1  p16 MLH1
Predictor β (95% CI) p-Value β (95% CI) p-Value β (95% CI) p-Value
Blood cadmium
Unadjusteda 0.16 (–0.46, 0.78) 0.61 0.11 (–0.38, 0.60) 0.65 0.14 (–0.52, 0.80) 0.69
Adjusted 1b 0.40 (–0.27, 1.07) 0.24 0.30 (–0.23, 0.83) 0.26 0.26 (–0.46, 0.98) 0.47
Adjusted 2c 0.45 (–0.23, 1.12) 0.19 0.24 (–0.29, 0.77) 0.37 0.19 (–0.53, 0.91) 0.61
Urinary cadmium
Unadjusteda  –0.50 (–0.86, –0.14) 0.0070 –0.13 (–0.42, 0.15) 0.37 –0.062 (–0.45, 0.33) 0.75
Adjusted 1b –0.44 (–0.83, –0.053) 0.026 –0.048 (–0.36, 0.26) 0.76 –0.0054 (–0.43, 0.42) 0.98
Adjusted 2c –0.42 (–0.82, –0.025) 0.038 –0.11 (–0.42, 0.21)  0.51 –0.073 (–0.50, 0.36) 0.74
β is the unstandardized regression coefficient.
aUnivariate analysis (n = 202): percent methyla  tion = α1 + β1 cadmium in blood/urine. bAdjusted analysis (n = 202): 
percent methyla  tion = α1 + β1 cadmium in blood/urine + β2 × age + β3 × coca chewing. cAdjusted analysis (n = 201): 
percent methyla  tion = α1 + β1 cadmium in blood/urine + β2 × age + β3 × coca chewing + β4 arsenic in urine.Hossain et al.
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after adjustments for age and coca chewing 
or after additional adjustment for urinary 
arsenic concentration (Table 2). Further 
adjustments for urinary boron, lithium, or 
cesium also had little influence on effect esti-
mates (data not shown). When the analysis 
for LINE-1 included an interaction term 
between cadmium and dichotomized arsenic 
in urine (median split), no significant inter-
action was detected (p = 0.37). Excluding the 
four smokers (which left n = 198) did not 
change the estimated association between uri-
nary cadmium and LINE methyla  tion (in fully 
adjusted model: β = –0.44; 95% CI: –0.85, 
–0.034). There was no association between ln-
transformed urinary or blood cadmium con-
centrations and p16 or MLH1 methyla  tion 
(Table 2).
The association of urinary cadmium with 
LINE-1 methyla  tion showed statistically 
signifi  cant interactions in unadjusted models 
with the genotypes DNMT1 rs10854076 and 
rs2228611 (Table 3). The association between 
urinary cadmium and LINE-1 methyla  tion 
was significantly stronger in carriers of the CC 
and CG genotypes of DNMT1 rs10854076 
than in common GG carriers, and in carriers 
of the rare GG DNMT1 rs2228611 genotype 
than in GA and AA carriers. DNMT3B geno-
types did not significantly modify the asso-
ciation between urinary cadmium and LINE-1 
methyla  tion, although associations were stron-
ger among women with the variant genotypes 
of both DNMT3B polymorphisms.
Characteristics of the 90 women included 
in the analyses of DNMT gene expression [see 
Supplemental Material, Table 1 (http://dx.doi.
org/10.1289/ehp.1104600)] were similar to 
those of all participants (Table 1), except that 
the subset was slightly younger (median, 32 
vs. 34 years; p = 0.019). DNMT1 expression 
in blood was much higher than DNMT3B 
expression (Table 4). DNMT3B _1733929 
[Illumina HT-12 transcripts are named 
ILMN_(number)] expression was significantly 
higher in DNMT1 rs10854076 CC and 
CG carriers than in GG carriers, and in 
DNMT3B rs2424913 TT carriers than in rare 
C allele carriers (Table 4). Urinary cadmium 
concentration was inversely correlated with 
expression of one DNMT3B transcript 
(ILMN_1733929; rS = –0.28, p = 0.0086) 
but not with the other four transcripts 
(rS = –0.12 to 0.20; p = 0.062–0.78) or with 
DNMT1 expression (rS = –0.075, p = 0.48). 
Urinary cadmium also was not associated 
with DNMT1 expression when stratified by 
DNMT1 rs10854076 genotype (CC + CG 
carriers: β = –19; 95% CI: –88, 50; GG 
carriers: β = 6.0; 95% CI: –63, 75) or by 
DNMT1 rs2228611 genotype (GG + GA 
carriers: β = –17.6; 95% CI: –80, 45; AA allele 
carriers: β = –0.60; 95% CI: –75, 74). There 
were no correlations between DNMT1 or 
DNMT3B (ILMN_1733929) expression and 
LINE-1 methyla  tion (rS = 0.050 and –0.16, 
respectively; p-values = 0.64 and 0.14).
Discussion
We found that low-level urinary cadmium 
in women, which represents life-long cad-
mium exposure, was inversely associated with 
LINE-1 methyla  tion, a marker of global DNA 
methyla  tion. Urinary cadmium exposure was 
also inversely associated with the expression 
of DNMT3B, which is involved in de novo 
CpG methyla  tion, but not with expression 
of DNMT1, which is primarily involved in 
maintaining CpG methyla  tion patterns in the 
genome. The inverse association between uri-
nary cadmium and LINE-1 methyla  tion var-
ied according to DNMT1 polymorphisms; the 
inverse association was stronger among carriers 
of the rare alleles of DNMT1 rs10854076 and 
rs2228611. The gene expression data from 
blood show associations between polymor-
phisms DNMT1 rs10854076 and DNMT3B 
rs2424913 and DNMT3B gene expression.
Most likely, diet was the main source of 
cadmium for the study subjects. Only a few of 
the women smoked cigarettes, another major 
source of cadmium exposure, and judging 
from their blood cadmium concentrations 
(0.18–0.52 µg/L), it can be assumed they 
did not smoke much. Furthermore, the 
study area has minimal industrial pollution 
and little vehicle traffic. The urine cadmium 
concentrations in our study population 
(median, 0.23 µg/L; range, 0.013–1.5 µg/L; 
or a median of 0.26 µg/g creatinine) were 
Table 3. Effect modification of DNMT1 and DNMT3B genotypes on the association between ln-transformed 
cadmium concentrations in urine and for LINE1 methyla  tion levels (n = 172 in all analyses).
Unadjusted analysis Adjusted analysis
Genotype βa (95% CI) p-Valueb βc (95% CI) p-Valued
DNMT1
rs10854076
CC (n = 25) –1.09 (–2.02, –0.15) 0.041 –0.99 (–2.03, 0.059) 0.045
CG (n = 69) –0.96 (–1.68, –0.24) –1.04 (–1.91, –0.17)
GG (n = 78) –0.052 (–0.58, 0.47) –0.053 (–0.61, 0.51)
rs2228611
GG (n = 35) –1.19 (–1.99, –0.40) 0.050 –1.04 (–1.96, –0.12) 0.064
GA (n = 68) –0.38 (–1.07, 0.31) –0.38 (–1.14, 0.38)
AA (n = 69) –0.10 (–0.67, 0.47) –0.13 (–0.75, 0.48)
DNMT3B
rs2424913
CC + CT (n = 15)  –1.22 (–3.20, 0.77) 0.39 –1.04 (–3.36, 1.27) 0.38
TT (n = 155) –0.45 (–0.84, –0.064) –0.39 (–0.81, 0.024)
rs2424932
AA + GA (n = 18)  –1.36 (–3.12, 0.40) 0.28 –1.43 (–3.39, 0.53) 0.25
GG (n = 152) –0.46 (–0.85, –0.065) –0.39 (–0.81, 0.037)
aPercent LINE1 methyla  tion (stratified for each genotype) = α1 + β1 cadmium. bp-Value interaction from term β3 in the 
model: percent LINE1 methyla  tion = α1 + β1 genotype + β2 cadmium + β3 (genotype × cadmium). cPercent LINE1 methyla-
tion (stratified for each genotype) = α1 + β1 cadmium + β2 age + β3 coca chewing. dp-Value interaction from term β3 in 
the model: percent LINE1 methyla  tion = α1 + β1 genotype + β2 cadmium + β3 (genotype × cadmium) + β4 age + β5 coca 
chewing.
Table 4. DNMT1 and DNMT3B gene expression according to DNMT1 and DNMT3B genotypes.a
DNMT1 DNMT3B
Genotype Gene expressionb p-Valuec p-Valued Gene expressionb p-Valuec p-Valued
DNMT1
rs10854076
CC (n = 8) 654.9 0.14 0.18 92.2 0.027 0.040
CG (n = 30) 640.3 90.0
GG (n = 37) 629.6 87.3
rs2228611
GG (n = 12) 653.6 0.18 0.18 91.0 0.23 0.26
GA (n = 31) 639.6 89.2
AA (n = 32) 591.4 87.8
DNMT3B
rs2424913
CC + CT (n = 7) 583.0  0.83 0.67 85.1 0.068 0.036
TT (n = 67) 640.0 89.2
rs2424932
AA + GA (n = 8)  559.0 0.68 0.38 86.4 0.19 0.11
GG (n = 66) 640.3 89.1
aDNMT1 is represented by one transcript (ILMN_1760201), whereas DNMT3B is represented by five transcripts (values 
from ILMN_1733929 presented here). DNMT genotypes were not associated with the expression of other DNMT3B 
transcripts (p > 0.1). bMedian, expressed as an arbitrary unit. cp-Value from model gene expression = α1 + β1 × genotype. 
dp-Value from model gene expression = α1 + β1 × genotype + β2 × age + β3 × coca chewing.Cadmium influences DNA methylation
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similar to those reported for women of similar 
age in the United States (median, 0.19 µg/g 
creatinine) (Gallagher et al. 2011). A slightly 
higher concentration has been reported for 
an Asian population (median, 0.59 µg/L), 
which is possibly due to dietary exposure 
through rice, which easily takes up cadmium 
from soil (Kippler et al. 2007). Thus, if the 
observed association between cadmium and 
hypomethyla  tion reflects a causal relation, 
effects may be common and stronger in groups 
with higher exposures, such as smokers and 
occupationally exposed workers. However, 
further studies in other populations, including 
occupationally exposed individuals, are 
warranted.
CpG sites in LINE-1 promoters are usu-
ally heavily methylated, and genome-wide 
methyla  tion loss from these sites has been 
regarded as a common epigenetic event in 
malignancies that may play a role in carcino-
genesis (Cho et al. 2010; Choi et al. 2009; 
Wilhelm et al. 2010). There is increasing con-
cern that cadmium acts as a metallo  estrogen 
(Fechner et al. 2011) and that it might 
increase the risk of hormone-related cancers 
in humans (Åkesson et al. 2008; Gallagher 
et al. 2010; Siewit et al. 2010). The association 
found in the present study between cadmium 
and LINE-1 hypomethyla  tion in women sug-
gests that cadmium can alter DNA methyla-
tion, which could be another mechanism for 
cadmium carcinogenesis. In vitro data lend 
some support to this hypothesis: Takiguchi 
et al. (2003) reported that cadmium expo-
sure of nontransformed rat cells resulted in the 
inhibition of methyltransferase activity and, at 
higher exposures, hypomethyla  tion. They also 
showed that after 10 weeks of exposure the 
cells became malignantly transformed and had 
increased methyltransferase activity. This phe-
nomenon has also been shown in malignantly 
transformed prostate epithelial cells: cadmium 
exposure increased DNMT enzymatic activity 
and overexpression of DNMT3B accompa-
nied by hypermethyla  tion (Benbrahim-Tallaa 
et al. 2007).
Little is known about the potential effects 
of environmental pollutants on LINE-1 
methyla  tion. In a recent U.S. bladder cancer 
case–control study, higher toenail concen-
trations of arsenic (> 75th percentile) were 
associated with reduced LINE-1 methyla  tion 
(Wilhelm et al. 2010). In contrast, urinary 
arsenic was not associated with LINE-1 in the 
present study. Possibly, this can be explained 
by specific genetic polymorphisms in the 
AS3MT [arsenic (+3 oxidation state) methyl-
transferase] gene that previously were found in 
the present study population to be associated 
with a very efficient methyla  tion and detox-
ification of inorganic arsenic (Engström K 
et al. 2011). Other factors may also influ-
ence LINE-1 methyla  tion. Exposure to coarse 
particulate matter (particulate matter with 
aerodynamic diameter ≤ 10 µm) (Tarantini 
et al. 2009) and black carbon (Baccarelli 
et al. 2009) were found to be inversely associ-
ated with LINE-1 methyla  tion in peripheral 
blood cells from humans. Maternal prenatal 
smoking was associated with lower LINE-1 
methyla  tion in buccal cells of preschool chil-
dren with gluta  thione S-transferase mu 1 
(GSTM1)-null genotype, whereas there was 
higher methyla  tion in the GSTM1-present 
children (Breton et al. 2009).
The maintenance of methyla  tion in 
somatic cells is largely carried out by DNMT1 
(Chen and Li 2006), and DNMT1 expression 
in normal peripheral blood has previously 
been reported to be higher than DNMT3B 
expression (Mizuno et al. 2001), consistent 
with our findings. DNMT1 and DNMT3B 
colocalize in the nucleus (Kim et al. 2002), 
and it has been shown that in cancer cells 
DNMT1 and DNMT3B work cooperatively 
to maintain DNA methyla  tion (Rhee et al. 
2002). Of note, the allelic frequencies of 
DNMT3B single-  nucleotide polymorphisms 
were low in the present study, limiting the 
possibility to detect modest gene–environment 
interactions. Further, because the levels of 
DNMT3B expression were lower than those of 
DNMT1, these findings should be interpreted 
cautiously.
There was no association between blood 
cadmium concentrations, which represent a 
measure of short-term exposure, and our mea-
sure of global DNA methyla  tion, although 
cadmium levels in blood and urine were 
moderately correlated. If a causal relation 
exists between cadmium exposure and DNA 
methyla  tion, one may speculate that the cad-
mium effect is chronic in nature or occurred 
a long time before the analyses, even early in 
life. Furthermore, we found no effect of blood 
hemoglobin, selenium, or zinc status on the 
epigenetic markers. The lack of association 
between selenium concentrations and global 
DNA methyla  tion in our study population 
is in contrast to the results of Pilsner et al. 
(2011), who measured plasma selenium in 
relation to global leukocyte DNA methyla-
tion. The difference in results may reflect 
differences in selenium status; the women 
in the present study all had adequate blood 
selenium concentrations (138–250 µg/L), 
whereas the Bangladeshi individuals studied 
by Pilsner et al. (2011) showed plasma con-
centrations of 45–149 µg/L (plasma concen-
trations are somewhat lower than selenium 
in whole blood), indicating lower selenium 
status. Other differences include the meth-
ods used to measure global DNA methyla-
tion: Pilsner et al. (2011) used a [3H]-methyl 
incorporation assay assessing methyla  tion at all 
genomic CpG sites, whereas we used bisulfite-
PCR pyrosequencing to quantitate LINE-1 
methyla  tion at four CpG sites, which served as 
a surrogate for global DNA methyla  tion.
We conducted this study on a fairly homo-
geneous population in which subjects differed 
very little in terms of diet, air pollution, and 
other lifestyle factors, including smoking 
and alcohol consumption. This homogene-
ity may explain the small variation in degree 
of LINE-1 methyla  tion we found compared 
with other studies (Choi et al. 2009; Tarantini 
et al. 2009). Also, we adjusted for other essen-
tial and toxic elements, such as arsenic, but 
these elements did not appear to modify the 
association between cadmium and LINE-1 
methyla  tion. A limitation of our study is that 
we measured methyla  tion in the DNA isolated 
from peripheral blood only and not from indi-
vidual cell populations or other tissues. DNA 
methyla  tion patterns may differ among blood 
cell types (Wu et al. 2011).
Conclusion
We found that low-level environmental 
cadmium exposure was associated with a 
marker of global DNA hypomethyla  tion in 
peripheral blood. This association was modified 
in relation to DNMT1 genotypes. Future 
studies are necessary to confirm our findings 
in other populations and determine whether 
cadmium-associated epigenetic modification is 
present in other tissues, and if epigenetic effects 
of cadmium may play a role in cadmium-
  associated diseases.
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